Back to the main directory
Press Release
- Indkaldelse til ordinær generalforsamling by GlobeNewsWire
- ARKO Corp. Subsidiary GPM Investments Launches a Major Upgrade to its fas REWARDS Loyalty App by GlobeNewsWire
- Elcora engages Lab 4 to design and build its Vanadium Pilot Plant by GlobeNewsWire
- Dayforce Wallet Momentum Continues with $1 Billion On-Demand Pay Milestone by GlobeNewsWire
- Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology by GlobeNewsWire
- EXL Schedules First Quarter 2023 Financial Results Conference Call by GlobeNewsWire
- Nexcella, an Immix Biopharma subsidiary, announces poster presentation at the European Society for Blood and Marrow Transplantation 49th Annual Meeting by GlobeNewsWire
- Kratos Delivers 200th Production Aircraft of BQM-177A Subsonic Aerial Target System by GlobeNewsWire
- Mission-Driven Health Care Insurer Renews and Modernizes its IT Operations with edgeTI by GlobeNewsWire
- Phathom Pharmaceuticals Announces Regulatory Update and Plans for 2023 Erosive Esophagitis and H. pylori Commercial Launch by GlobeNewsWire
- Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel's Ministry of Health by GlobeNewsWire
- Caribou Biosciences Announces FDA Granted Fast Track Designation to CB-011, an Allogeneic CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma by GlobeNewsWire
- electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through the Carrick Institute by GlobeNewsWire
- Mullen Automotive Accelerates Implementation of Its Solid-State Polymer Battery Technology to Integrate with Class 1 EV Cargo Vans by GlobeNewsWire
- BullFrog AI Announces Exclusive, Worldwide Licensing Agreement with Johns Hopkins’ Applied Physics Laboratory for Patented AI Technology by GlobeNewsWire
- CAVForth autonomous bus service to launch in May with Enviro200AV fleet from NFI’s Alexander Dennis by GlobeNewsWire
- EQS-News: AiCuris AG ernennt Larry Edwards zum Chief Executive Officer und gibt die Gründung einer US-Tochtergesellschaft bekannt by EQS Group AG
- EQS-News: Eckert & Ziegler beliefert POINT Biopharma mit Actinium-225 by EQS Group AG
- Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers by GlobeNewsWire
- Manhattan Associates Named a Leader in 2023 Gartner® Magic Quadrant™ for Transportation Management Systems for the Fifth Consecutive Year by BusinessWire
- SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome by GlobeNewsWire
- Adtran joins SoFiN project to drive flexible, low-cost multi-sensing for critical industries by BusinessWire
- Premier, Inc. to Report Fiscal 2023 Third-Quarter Results and Host Conference Call on May 2, 2023 by BusinessWire
- Ryman Hospitality Properties Announces 2023 Board of Directors Slate; Adds Former Tennessee Governor Bill Haslam as a Director Nominee by GlobeNewsWire
- Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board by GlobeNewsWire
- Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023 by GlobeNewsWire
- SLR Investment Corp. Announces Monthly Distribution for April 2023 by GlobeNewsWire
- ABB invests $170 million in the U.S. by GlobeNewsWire
- Enlivex Announces Tislelizumab Clinical Collaboration, Full Year 2022 Financial Results, and Provides Business Updates by GlobeNewsWire
- Rafael Holdings Announces up to $5 Million Share Repurchase Program by GlobeNewsWire
- Compass Diversified-Backed Marucci Sports Announces Acquisition of Baum Bat by GlobeNewsWire
- OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report by GlobeNewsWire
- SAB Biotherapeutics Announces Appointment of Erick Lucera, CFA to Board of Directors by GlobeNewsWire
- Hypeart brings its first-ever group art exhibition to the U.S., entitled NOISY REALITY by GlobeNewsWire
- ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments by GlobeNewsWire
- Ayr Wellness Announces Leadership Update by GlobeNewsWire
- Asia Broadband Confirms Mining Registry Update For Its Bonanza Gold Mine Project As Development and Drilling Program Continues by GlobeNewsWire
- Decklar Updates Crude Oil Trucking Operations and Sales at the Oza Oil Field by GlobeNewsWire
- Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes by GlobeNewsWire
- Eckert & Ziegler to Supply POINT Biopharma with Actinium-225 by GlobeNewsWire
- Tri Pointe Homes Earns 100 Best Companies to Work For® Recognition From Fortune Magazine and Great Place to Work® by GlobeNewsWire
- EQS-News: AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary by EQS Group AG
- EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225 by EQS Group AG
- Victoire d’une classe de Blonay/Saint-Légier pour cette 18ème édition du Challenge des Explorateurs de l’Énergie by EQS Group AG
- Vishay Intertechnology Announces 2023 Annual Meeting of Stockholders by GlobeNewsWire
- Startek Recognized by Comparably for Best Global Culture and Best HR Teams by BusinessWire
- REPAY to Power Accounts Payable Payments for Optima Global Solutions by BusinessWire
- Issue of Equity and Total Voting Rights by GlobeNewsWire
- Consolidated Water Announces Passing of Richard L. Finlay, Long-Standing Director and Friend by GlobeNewsWire
- LIXTE Biotechnology Announces Sarah Cannon Research Institute Joins City of Hope’s Ongoing Phase 1b Clinical Trial in Evaluating Lixte’s Lead Anti-Cancer Compound, LB-100, in Small Cell Lung Cancer by GlobeNewsWire